DK1059092T3 - Anvendelse af komplekser af kationiske liposomer og polydeoxyribonukleotider som medikamenter - Google Patents
Anvendelse af komplekser af kationiske liposomer og polydeoxyribonukleotider som medikamenterInfo
- Publication number
- DK1059092T3 DK1059092T3 DK99111118T DK99111118T DK1059092T3 DK 1059092 T3 DK1059092 T3 DK 1059092T3 DK 99111118 T DK99111118 T DK 99111118T DK 99111118 T DK99111118 T DK 99111118T DK 1059092 T3 DK1059092 T3 DK 1059092T3
- Authority
- DK
- Denmark
- Prior art keywords
- complexes
- polydeoxyribonucleotides
- cationic liposomes
- drugs
- polydeoxyribonucletoides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99111118A EP1059092B1 (en) | 1999-06-08 | 1999-06-08 | Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments |
CA002274419A CA2274419A1 (en) | 1999-06-08 | 1999-06-11 | Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments |
US09/330,215 US6767554B2 (en) | 1999-06-08 | 1999-06-11 | Use of complexes among cationic liposomes and polydeoxyribonucleotides and medicaments |
AU35010/99A AU776014B2 (en) | 1999-06-11 | 1999-06-11 | Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments |
KR1019990021947A KR100676492B1 (ko) | 1999-06-08 | 1999-06-12 | 양이온성 리포솜 및 폴리데옥시리보누클레오티드 사이의 복합체의 약제로서의 용도 |
JP16700999A JP4598908B2 (ja) | 1999-06-08 | 1999-06-14 | カチオン性リポソームとポリデオキシリボヌクレオチドとの複合体 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1059092T3 true DK1059092T3 (da) | 2006-03-27 |
Family
ID=32330163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99111118T DK1059092T3 (da) | 1999-06-08 | 1999-06-08 | Anvendelse af komplekser af kationiske liposomer og polydeoxyribonukleotider som medikamenter |
Country Status (9)
Country | Link |
---|---|
US (1) | US6767554B2 (ko) |
EP (1) | EP1059092B1 (ko) |
JP (1) | JP4598908B2 (ko) |
KR (1) | KR100676492B1 (ko) |
AT (1) | ATE311907T1 (ko) |
CA (1) | CA2274419A1 (ko) |
DE (1) | DE69928778T2 (ko) |
DK (1) | DK1059092T3 (ko) |
ES (1) | ES2251134T3 (ko) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7129087B2 (en) | 2000-10-12 | 2006-10-31 | The Public Health Research Institute Of The City Of New York, Inc. | Oligonucleotide-facilitated coalescence |
PT1530465E (pt) * | 2002-06-26 | 2010-01-05 | Medigene Ag | Processo para produção de uma preparação lipossomal catiónica que compreende um composto lipofílico |
JP2006193461A (ja) * | 2005-01-13 | 2006-07-27 | Pola Chem Ind Inc | 毛髪用の洗浄料 |
ITMI20051303A1 (it) * | 2005-07-08 | 2007-01-09 | Inxel S R L | Metodo per la produzione di vernici in polvere termoindurenti particolarmente per l'applicazione mediante impianti elettrostatici |
EP1872787A1 (en) * | 2006-06-27 | 2008-01-02 | Gentium S.p.A. | Use of defibrotide for the inhibition of heparanase |
JPWO2008093848A1 (ja) * | 2007-02-02 | 2010-05-20 | サンスター株式会社 | ホスファチジルコリンを含有する炎症マーカー低減組成物 |
EP2103689A1 (en) * | 2008-03-19 | 2009-09-23 | Gentium S.p.A. | Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
US20100279353A1 (en) * | 2009-04-30 | 2010-11-04 | Shiu Nan Chen | Process of producing fibrinolytic enzyme from mushroom |
JP5142295B2 (ja) * | 2009-05-08 | 2013-02-13 | 独立行政法人農業・食品産業技術総合研究機構 | ベシクル及びその製法 |
WO2010135714A2 (en) | 2009-05-22 | 2010-11-25 | The Methodist Hospital Research Institute | Methods for modulating adipocyte expression using microrna compositions |
DK2637672T3 (en) | 2010-11-12 | 2018-10-22 | Gentium S R L | DEFIBROTID FOR USE IN PROPHYLAXY AND / OR TREATMENT OF GRAPHIC VERSUS HOST DISEASE (GVHD) |
GB201204632D0 (en) * | 2012-03-16 | 2012-05-02 | Univ Belfast | Delivery system |
WO2013190582A1 (en) | 2012-06-22 | 2013-12-27 | Gentium S.P.A. | Euglobulin-based method for determining the biological activity of defibrotide |
US11086970B2 (en) | 2013-03-13 | 2021-08-10 | Blue Belt Technologies, Inc. | Systems and methods for using generic anatomy models in surgical planning |
KR101534276B1 (ko) * | 2014-07-18 | 2015-07-07 | 주식회사 에스씨301테라피 | 지방 이식 수술 후 지방세포 성장 및 생착 증진을 위한 조성물 |
EP3026122A1 (en) | 2014-11-27 | 2016-06-01 | Gentium S.p.A. | Cellular-based method for determining the potency of defibrotide |
EP3661484A1 (en) | 2017-08-03 | 2020-06-10 | Jazz Pharmaceuticals Ireland Limited | Formulations comprising a nucleic acid in a high concentration |
WO2019188867A1 (ja) | 2018-03-27 | 2019-10-03 | 日油株式会社 | 細胞内動態を改善した新規カチオン性脂質 |
CN112236149A (zh) | 2018-04-12 | 2021-01-15 | 贾兹制药公司 | 用于预防和治疗细胞因子释放综合征和与免疫耗竭相关的神经毒性的去纤苷 |
KR102144615B1 (ko) * | 2018-08-09 | 2020-08-13 | 장건주 | 폴리데옥시리보뉴클레오타이드를 포함하는 마이셀, 약물 전달체 및 이의 제조방법 |
KR102132478B1 (ko) * | 2018-11-15 | 2020-07-10 | (주)진우바이오 | 히알루론산-폴리데옥시리보뉴클레오타이드 복합체와 이를 활용한 필름 및 이의 제조방법 |
WO2020118165A1 (en) | 2018-12-07 | 2020-06-11 | Jazz Pharmaceuticals Ireland Limited | Subcutaneous delivery of high concentration formulations |
JPWO2021060440A1 (ko) | 2019-09-26 | 2021-04-01 | ||
US20230190783A1 (en) | 2020-02-28 | 2023-06-22 | Jazz Pharmaceuticals Ireland Limited | Delivery of low viscosity formulations |
WO2022234101A1 (en) | 2021-05-06 | 2022-11-10 | Jazz Pharmaceuticals Ireland Limited | Defibrotide for the treatment and prevention of acute respiratory distress syndrome |
WO2024106783A1 (ko) * | 2022-11-14 | 2024-05-23 | 주식회사 스템온 | 폴리데옥시리보뉴클레오티드를 포함하는 엑소좀, 이를 포함하는 조성물 및 이의 제조방법 |
CN115737470A (zh) * | 2022-11-25 | 2023-03-07 | 润辉生物技术(威海)有限公司 | 一种肌肽-pdrn复合物及其制备方法和应用 |
CN115836982B (zh) * | 2022-12-30 | 2024-02-06 | 南京乐韬生物科技有限公司 | 一种含pdrn的纳米乳液及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1043823B (it) | 1970-11-03 | 1980-02-29 | Prephar | Procedimento per l estrazione di acidi nucleici da organi animali |
DE3017154A1 (de) | 1980-05-05 | 1981-11-12 | Hoechst Ag, 6000 Frankfurt | Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3,-heptafluor-propan |
HU192909B (en) * | 1985-01-17 | 1987-07-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing interfuranylene-prostacycline derivatives |
IT1190313B (it) * | 1986-04-17 | 1988-02-16 | Crinos Industria Farmaco | Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante |
ATE107502T1 (de) * | 1988-10-05 | 1994-07-15 | Vestar Inc | Verfahren zur herstellung von liposomen mit verbesserter stabilität während des trocknens. |
JPH04503957A (ja) * | 1989-03-07 | 1992-07-16 | ジェネンテク,インコーポレイテッド | 脂質とオリゴヌクレオチドの共有結合コンジュゲート |
EP0451791A2 (de) * | 1990-04-12 | 1991-10-16 | Hoechst Aktiengesellschaft | Langwirksame Liposomenpräparate von Peptidarzneistoffen und Verfahren zu ihrer Herstellung |
ES2104790T3 (es) | 1991-11-01 | 1997-10-16 | Solvay | Procedimiento para la preparacion de 1,1,1,2,3,3,3-heptafluoropropano (r227). |
IT1252174B (it) * | 1991-12-09 | 1995-06-05 | Crinos Industria Farmaco | Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento |
DE59303465D1 (de) | 1992-03-26 | 1996-09-26 | Hoechst Ag | Verfahren zur Reaktivierung eines bei der Herstellung von 1,1,1,2,3,3,3-Heptafluorpropan (R 227) eingesetzten Aktivkohle-Katalysators |
US5395619A (en) * | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
DE4323054A1 (de) | 1993-07-14 | 1995-01-19 | Hoechst Ag | Verfahren zur Herstellung von 2-H-Heptafluorpropan |
US6071890A (en) * | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
US5908777A (en) * | 1995-06-23 | 1999-06-01 | University Of Pittsburgh | Lipidic vector for nucleic acid delivery |
KR19990036033A (ko) * | 1995-08-01 | 1999-05-25 | 한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 | 리포소옴성 올리고뉴클레오티드 조성물 |
US5837283A (en) * | 1997-03-12 | 1998-11-17 | The Regents Of The University Of California | Cationic lipid compositions targeting angiogenic endothelial cells |
-
1999
- 1999-06-08 DK DK99111118T patent/DK1059092T3/da active
- 1999-06-08 ES ES99111118T patent/ES2251134T3/es not_active Expired - Lifetime
- 1999-06-08 EP EP99111118A patent/EP1059092B1/en not_active Expired - Lifetime
- 1999-06-08 AT AT99111118T patent/ATE311907T1/de active
- 1999-06-08 DE DE69928778T patent/DE69928778T2/de not_active Expired - Lifetime
- 1999-06-11 CA CA002274419A patent/CA2274419A1/en not_active Abandoned
- 1999-06-11 US US09/330,215 patent/US6767554B2/en not_active Expired - Lifetime
- 1999-06-12 KR KR1019990021947A patent/KR100676492B1/ko not_active IP Right Cessation
- 1999-06-14 JP JP16700999A patent/JP4598908B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69928778D1 (de) | 2006-01-12 |
ATE311907T1 (de) | 2005-12-15 |
EP1059092A1 (en) | 2000-12-13 |
DE69928778T2 (de) | 2006-07-06 |
JP2001002565A (ja) | 2001-01-09 |
ES2251134T3 (es) | 2006-04-16 |
US6767554B2 (en) | 2004-07-27 |
KR20010002244A (ko) | 2001-01-15 |
KR100676492B1 (ko) | 2007-01-30 |
US20020142029A1 (en) | 2002-10-03 |
EP1059092B1 (en) | 2005-12-07 |
CA2274419A1 (en) | 2000-12-11 |
JP4598908B2 (ja) | 2010-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1059092T3 (da) | Anvendelse af komplekser af kationiske liposomer og polydeoxyribonukleotider som medikamenter | |
DE3786000D1 (de) | Conjugate dichter sterne. | |
NO20020033D0 (no) | Zwitterioniske polymerer med höy molekylvekt | |
DE60033179D1 (de) | Modifizierte polymere hergestellt mit katalysatoren auf basis von lanthaniden | |
CY1108279T1 (el) | 17α-ΑΛΚΥΛΟ-17β-ΟΞΥ-ΟΙΣΤΡΑΤΡΙΕΝΙΑ ΚΑΙ ΕΝΔΙΑΜΕΣΑ ΠΡΟΪΟΝΤΑ ΓΙΑ ΤΗΝ ΠΑΡΑΓΩΓΗ ΑΥΤΩΝ, Η ΧΡΗΣΗ ΤΩΝ 17α-ΑΛΚΥΛΟ-17β-ΟΞΥ-ΟΙΣΤΡΑΤΡΙΕΝΙΩΝ ΓΙΑ ΤΗΝ ΠΑΡΑΓΩΓΗ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΜΕΣΩΝ ΚΑΘΩΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΑ ΠΑΡΑΣΚΕΥΑΣΜΑΤΑ | |
DE60016271D1 (de) | Medikamentenzuführvorrichtung | |
ID23357A (id) | Alas pembawa anak anak | |
FR2862975B1 (fr) | Nouveaux agents epaississants a motifs cationiques et leur procede de preparation. | |
DE60009708T2 (de) | Gewinnung von propan | |
DE60138271D1 (de) | Herstellung von DIBENZOÄB,FÜAZEPINE ZWISCHENPRODUKTE | |
ATE260105T1 (de) | Zubereitung enthaltend eine molekulardispersion mit erhöhter bioverfügbarkeit | |
BR0004161B1 (pt) | solução de molho ácido. | |
ATE318834T1 (de) | Lipide mit aminoxygruppe | |
DE60008248D1 (de) | Polymerisationskatalysatoren | |
ZA9610511B (en) | Covalent lipid-phosphonocarboxylic acid conjugates, the production thereof as well as their use as antiviral pharmaceutical agents. | |
MA26677A1 (fr) | Medicaments antiparkinsoniens. | |
AU2507601A (en) | 11-beta-phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, production thereof and pharmaceutical compositions containing these compounds | |
ID28707A (id) | 1,2,4-trioksan tersubstitusi sebagai obat anti malaria dan metode pembuatannya | |
IT1311974B1 (it) | Polimeri dell'etilene. | |
ITRA970003U1 (it) | Lettino da bambini con rotelle dondolabile. | |
ITMI960686A1 (it) | Figurina adesiva con effetto tridimensionale o in rilievo,a ridotto costo di produzione,particolarmente per bambini. | |
IT248917Y1 (it) | Montante piatto per costruzioni componibili legate all'infanzia. | |
FI905644A0 (fi) | Med pseudomonas aeruginosa reaktiva maenniskans monoklonala motkroppar, celler som kan producera dessa, foerfaranden foer framstaellning av dessa och farmaceutiska preparat innehaollande dessa. | |
ES1044326Y (es) | Mesa armable infantil. | |
FR2770401B1 (fr) | Medicaments homeopathiques associant : antimonium crudum, antimonium tartaricum, natrum phosphoricum, adrenalinum, secale cornutum |